Literature DB >> 30430206

Intensive care medicine in 2050: clinical trials designs.

M Gasparini1, S Chevret2,3.   

Abstract

Year:  2018        PMID： 30430206     DOI： 10.1007/s00134-018-5364-9

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  14 in total

1.  Sample size correction for treatment crossovers in randomized clinical trials with a survival endpoint.

Authors:  Raphaël Porcher; Vincent Lévy; Sylvie Chevret
Journal:  Control Clin Trials       Date:  2002-12

2.  Statistical controversies in clinical research: scientific and ethical problems with adaptive randomization in comparative clinical trials.

Authors:  P Thall; P Fox; J Wathen
Journal:  Ann Oncol       Date:  2015-05-15       Impact factor: 32.976

3.  The mixed randomized trial: combining randomized, pragmatic and observational clinical trial designs.

Authors:  Jonathan Alsop; Martin Scott; William Archey
Journal:  J Comp Eff Res       Date:  2016-09-12       Impact factor: 1.744

Review 4.  Precision oncology: A new era of cancer clinical trials.

Authors:  Lindsay A Renfro; Ming-Wen An; Sumithra J Mandrekar
Journal:  Cancer Lett       Date:  2016-03-14       Impact factor: 8.679

Review 5.  Cancer biomarkers: selecting the right drug for the right patient.

Authors:  Gary J Kelloff; Caroline C Sigman
Journal:  Nat Rev Drug Discov       Date:  2012-02-10       Impact factor: 84.694

6.  Delta inflation: a bias in the design of randomized controlled trials in critical care medicine.

Authors:  Scott K Aberegg; D Roxanne Richards; James M O'Brien
Journal:  Crit Care       Date:  2010-04-29       Impact factor: 9.097

7.  Flexible trial design in practice - stopping arms for lack-of-benefit and adding research arms mid-trial in STAMPEDE: a multi-arm multi-stage randomized controlled trial.

Authors:  Matthew R Sydes; Mahesh K B Parmar; Malcolm D Mason; Noel W Clarke; Claire Amos; John Anderson; Johann de Bono; David P Dearnaley; John Dwyer; Charlene Green; Gordana Jovic; Alastair W S Ritchie; J Martin Russell; Karen Sanders; George Thalmann; Nicholas D James
Journal:  Trials       Date:  2012-09-15       Impact factor: 2.279

Review 8.  A path to precision in the ICU.

Authors:  David M Maslove; Francois Lamontagne; John C Marshall; Daren K Heyland
Journal:  Crit Care       Date:  2017-04-03       Impact factor: 9.097

9.  Adaptive designs in clinical trials: why use them, and how to run and report them.

Authors:  Philip Pallmann; Alun W Bedding; Babak Choodari-Oskooei; Munyaradzi Dimairo; Laura Flight; Lisa V Hampson; Jane Holmes; Adrian P Mander; Lang'o Odondi; Matthew R Sydes; Sofía S Villar; James M S Wason; Christopher J Weir; Graham M Wheeler; Christina Yap; Thomas Jaki
Journal:  BMC Med       Date:  2018-02-28       Impact factor: 8.775

Review 10.  Arguing for Adaptive Clinical Trials in Sepsis.

Authors:  Victor B Talisa; Sachin Yende; Christopher W Seymour; Derek C Angus
Journal:  Front Immunol       Date:  2018-06-28       Impact factor: 7.561
View more
  1 in total

1.  Personalization of renal replacement therapy initiation: a secondary analysis of the AKIKI and IDEAL-ICU trials.

Authors:  Jean-Pierre Quenot; Didier Dreyfuss; Stéphane Gaudry; François Grolleau; Raphaël Porcher; Saber Barbar; David Hajage; Abderrahmane Bourredjem
Journal:  Crit Care       Date:  2022-03-21       Impact factor: 9.097
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.